4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-011010
Chief Medical Officer sold 3,156 shares at an average $70.33 ($221,972)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2021-02-11 | Sale | −2,756 | $70.17 | $193,377 | 172,633 | I |
| Ho Carole Chief Medical Officer | 2021-02-11 | Sale | −400 | $71.49 | $28,594 | 172,233 | I |
| Open-market sales · 3,156 sh · avg $70.33 · $221,972 | |||||||
Loading xslF345X03/doc4.xml…